Physician profile
Glenn Kelley
NPI 1417985813
$3,828.68
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,426 · 2020: $385 · 2021: $891 · 2022: $999 · 2023: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $127.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $593.30 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $509.47 | 2019-2022 | |
| Pfizer INC. | $466.35 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $361.52 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $340.74 | 2019-2022 | |
| Amgen INC. | $327.19 | 2019-2022 | |
| Amarin Pharma, INC. | $233.42 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $199.06 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $99.77 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $92.66 | 2019-2022 | |
| Abiomed | $78.65 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $71.05 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $65.92 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $53.00 | 2019 | |
| Baxter Healthcare | $49.24 | 2023 | Hillrom - Carnation Ambulatory Monitor |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $47.96 | 2022-2023 | Cardiomems |
| Medtronic, INC. | $40.52 | 2021-2022 | |
| Gilead Sciences, INC. | $27.56 | 2019 | |
| Atricure, INC. | $27.39 | 2022 | |
| Medtronic Vascular, INC. | $26.12 | 2019-2020 | |
| Biosense Webster, INC. | $24.97 | 2023 | Carto 3 |
| Esperion Therapeutics, INC. | $17.65 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $16.85 | 2019 | |
| Ge Healthcare | $16.17 | 2023 | |
| Kestra Medical Technology Services, INC. | $15.24 | 2022 | |
| Boston Scientific Corporation | $14.02 | 2023 | Ekosonic |
| Astrazeneca Pharmaceuticals LP | $12.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.